Quote:
Originally Posted by tummyman
From what I read, it appears sometime in February and then followed by Astra Zeneca and Novavax in maybe March. I think both of those vaccines will also require two shots but do not hold me to that. So far, it seems only J&J is a one shot deal and even then, they are looking at whether two shots might be even better on efficacy. J&J has also been having some manufacturing problems. There is no real way to determine what vaccine you will get, unless you wait until the very end and vaccines become much more readily available. The government pre-bought a lot of doses of Moderna and Pfizer, so they will be probably pushing those out first.
|
The US pre-purchased 100 million doses of the J&J vaccine, and once approved I'd expect it to be the go-to option provided the efficacy is on par with the Moderna and Pfizer vaccines due to it being a one shot and done deal. J&J has already said that they anticipate having those 100 million doses all produced by spring provided the trial is a success and is granted EUA from the FDA. If J&J is approved, the light at the end of the tunnel gets a whole lot closer/brighter.